Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2025-12-25 @ 1:50 PM
NCT ID: NCT01362192
Description: None
Frequency Threshold: 0
Time Frame: 24 weeks
Study: NCT01362192
Study Brief: Treatment of Lower Extremity Spider Veins With Excel V
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
532 nm KTP Laser Treatment Each subject will receive 532 nm KTP laser treatment for their lower extremity spider veins None None 0 20 20 20 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Moderate Erythema Post-TX#1 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Erythema (redness) View
Mild Edema Immediate Post-TX#2 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Edema (swelling) View
Moderate Edema Immediate Post-TX#2 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Edema (swelling) View
Mild Erythema Post-TX#2 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Erythema (redness) View
Moderate Erythema Post-TX#2 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Erythema (redness) View
Mild Erythema Immediate Post-TX#1 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Erythema (redness) View
Post-Inflammatory Hyperpigmentation at 24 weeks NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Mild Edema Immediate Post-TX #1 SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders Edema (swelling) View